Personalized Diagnosis and Therapy for Multiple Sclerosis

• Muut tekijät: Ramo-Tello, Cristina M. (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: MDPI - Multidisciplinary Digital Publishing Institute 2022
• Aiheet: Public health & preventive medicine; cognition; cognitive impairment; neuroimaging; longitudinal; predictors; multiple sclerosis; lifestyle behavior; MS management; MS phenotype; quality of life; natalizumab; extended interval dose; biomarker; CD49d; sVCAM-1; immunomonitoring; personalized dose; prognosis; machine learning; artificial intelligence; relapse; pseudo-relapses; methylprednisolone; treatment algorithm; multiple sclerosis treatment; escalating strategy; he-DMT; diseases modifying therapies; early intense therapy; teleconsultation; internet; feasibility; digital health; neuromyelitis optica spectrum disorder; health-related quality of life; mood; n/a
• Linkit: DOAB: download the publication; DOAB: description of the publication

We all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The tre...